End-of-day quote
Other stock markets
|
||
- GBX | - |
|
07-15 | Jet2 chair buys; Ovoca Bio's old CEO sells to new | AN |
05-24 | Michael Ashcroft ups stake in Marlowe to 16% | AN |
Sales 2022 | - | Sales 2023 | - | Capitalization | 50.97M 69.72M |
---|---|---|---|---|---|
Net income 2022 | -2M -2.74M | Net income 2023 | -1M -1.37M | EV / Sales 2022 | - |
Net cash position 2022 | 2.44M 3.34M | Net cash position 2023 | 1.97M 2.69M | EV / Sales 2023 | - |
P/E ratio 2022 |
-9.65
x | P/E ratio 2023 |
-24
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 59.57% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Child
CEO | Chief Executive Officer | 62 | 06-05-23 |
Andrew Pearce
DFI | Director of Finance/CFO | - | - |
Dave Crawford
CTO | Chief Tech/Sci/R&D Officer | - | 14-03-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jim Mellon
CHM | Chairman | 68 | 11-04-05 |
John Stalker
BRD | Director/Board Member | 73 | 19-11-20 |
Denham Eke
BRD | Director/Board Member | 73 | 22-12-21 |
1st Jan change | Capi. | |
---|---|---|
+16.74% | 55.6B | |
+39.45% | 38.19B | |
+9.94% | 33.7B | |
+29.97% | 28.16B | |
+59.50% | 12.44B | |
+58.98% | 11.45B | |
+5.79% | 10.78B | |
+15.79% | 9.21B | |
-.--% | 8.96B |